Lillydendycasinonodepositbonus.US) rose more than 4%dendycasinonodepositbonus, the highest hit 816dendycasinonodepositbonus. 61 US dollars, a record high since listing. On the news front, on May 21, the official website of the State Food and Drug Administration showed that Lilly Mofonda (tierpositide injection) was approved by the State Food and Drug Administration (NMPA) to improve the treatment of adult patients with type 2 diabetesdendycasinonodepositbonusBlood sugar control. Tilpositide is a GIPR and GLP-1R agonist injected once a week.